Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
"Bath Salts" intoxication with multiorgan failure and left-sided ischemic colitis: a case report.

Hippokratia

Gavriilidis G, Kyriakoudi A, Tiniakos D, Rovina N, Koutsoukou A.
PMID: 27703310
Hippokratia. 2015 Oct-Dec;19(4):363-365.

BACKGROUND: In the recent years, a new group of designer drugs, under the brand name of bath salts has emerged as a new trend. They are mainly b-ketone amphetamine analogs and are derivatives of cathinone, a monoamine alkaloid. They...

Cite
Gavriilidis G, Kyriakoudi A, Tiniakos D, et al. "Bath Salts" intoxication with multiorgan failure and left-sided ischemic colitis: a case report. Hippokratia. 2015;19(4):363-365
Gavriilidis, G., Kyriakoudi, A., Tiniakos, D., Rovina, N., & Koutsoukou, A. (2015). "Bath Salts" intoxication with multiorgan failure and left-sided ischemic colitis: a case report. Hippokratia, 19(4), 363-365.
Gavriilidis, G, et al. ""Bath Salts" intoxication with multiorgan failure and left-sided ischemic colitis: a case report." Hippokratia vol. 19,4 (2015): 363-365.
Gavriilidis G, Kyriakoudi A, Tiniakos D, Rovina N, Koutsoukou A. "Bath Salts" intoxication with multiorgan failure and left-sided ischemic colitis: a case report. Hippokratia. 2015 Oct-Dec;19(4):363-365. PMID: 27703310; PMCID: PMC5033150.
Copy Download .nbib Format: NLM
Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease.

Annals of gastroenterology

Papageorgiou MV, Hadziyannis E, Tiniakos D, Georgiou A, Margariti A, Kostas A, Papatheodoridis GV.
PMID: 28243042
Ann Gastroenterol. 2017;30(2):209-216. doi: 10.20524/aog.2016.0107. Epub 2016 Dec 01.

BACKGROUND: This study aimed to assess the significance of serum levels of vascular endothelial growth factor (VEGF) in non-alcoholic fatty liver disease (NAFLD).METHODS: Sixty-seven consecutive NAFLD patients and 47 healthy controls who visited our liver clinics between May 2008...

Cite
Papageorgiou MV, Hadziyannis E, Tiniakos D, et al. Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Ann Gastroenterol. 2016;30(2):209-216doi: 10.20524/aog.2016.0107.
Papageorgiou, M. V., Hadziyannis, E., Tiniakos, D., Georgiou, A., Margariti, A., Kostas, A., & Papatheodoridis, G. V. (2017). Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Annals of gastroenterology, 30(2), 209-216. https://doi.org/10.20524/aog.2016.0107
Papageorgiou, Maria-Vasiliki, et al. "Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease." Annals of gastroenterology vol. 30,2 (2017): 209-216. doi: https://doi.org/10.20524/aog.2016.0107
Papageorgiou MV, Hadziyannis E, Tiniakos D, Georgiou A, Margariti A, Kostas A, Papatheodoridis GV. Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Ann Gastroenterol. 2017;30(2):209-216. doi: 10.20524/aog.2016.0107. Epub 2016 Dec 01. PMID: 28243042; PMCID: PMC5320034.
Copy Download .nbib Format: NLM
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.

JHEP reports : innovation in hepatology

Boyle M, Tiniakos D, Schattenberg JM, Ratziu V, Bugianessi E, Petta S, Oliveira CP, Govaere O, Younes R, McPherson S, Bedossa P, Nielsen MJ, Karsdal M, Leeming D, Kendrick S, Anstee QM.
PMID: 32039369
JHEP Rep. 2019 Jul 04;1(3):188-198. doi: 10.1016/j.jhepr.2019.06.004. eCollection 2019 Sep.

There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed...

Cite
Boyle M, Tiniakos D, Schattenberg JM, et al. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease. JHEP Rep. 2019;1(3):188-198doi: 10.1016/j.jhepr.2019.06.004.
Boyle, M., Tiniakos, D., Schattenberg, J. M., Ratziu, V., Bugianessi, E., Petta, S., Oliveira, C. P., Govaere, O., Younes, R., McPherson, S., Bedossa, P., Nielsen, M. J., Karsdal, M., Leeming, D., Kendrick, S., & Anstee, Q. M. (2019). Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease. JHEP reports : innovation in hepatology, 1(3), 188-198. https://doi.org/10.1016/j.jhepr.2019.06.004
Boyle, Marie, et al. "Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease." JHEP reports : innovation in hepatology vol. 1,3 (2019): 188-198. doi: https://doi.org/10.1016/j.jhepr.2019.06.004
Boyle M, Tiniakos D, Schattenberg JM, Ratziu V, Bugianessi E, Petta S, Oliveira CP, Govaere O, Younes R, McPherson S, Bedossa P, Nielsen MJ, Karsdal M, Leeming D, Kendrick S, Anstee QM. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease. JHEP Rep. 2019 Jul 04;1(3):188-198. doi: 10.1016/j.jhepr.2019.06.004. eCollection 2019 Sep. PMID: 32039369; PMCID: PMC7001575.
Copy Download .nbib Format: NLM
Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Clinical and experimental rheumatology

Albayda J, Christopher-Stine L, Bingham Iii CO, Paik JJ, Tiniakou E, Billings S, Uy OM, Burlina P.
PMID: 31111821
Clin Exp Rheumatol. 2019 May-Jun;37(3):518. Epub 2019 May 21.

No abstract available.

Cite
Albayda J, Christopher-Stine L, Bingham Iii CO, et al. Pattern of muscle involvement in inclusion body myositis: a sonographic study. Clin Exp Rheumatol. 2019;37(3):518
Albayda, J., Christopher-Stine, L., Bingham Iii, C. O., Paik, J. J., Tiniakou, E., Billings, S., Uy, O. M., & Burlina, P. (2019). Pattern of muscle involvement in inclusion body myositis: a sonographic study. Clinical and experimental rheumatology, 37(3), 518.
Albayda, Jemima, et al. "Pattern of muscle involvement in inclusion body myositis: a sonographic study." Clinical and experimental rheumatology vol. 37,3 (2019): 518.
Albayda J, Christopher-Stine L, Bingham Iii CO, Paik JJ, Tiniakou E, Billings S, Uy OM, Burlina P. Pattern of muscle involvement in inclusion body myositis: a sonographic study. Clin Exp Rheumatol. 2019 May-Jun;37(3):518. Epub 2019 May 21. PMID: 31111821.
Copy Download .nbib Format: NLM
Bizarre stromal cells in Crohn's disease.

Annals of gastroenterology

Iliakopoulos K, Tzikanoulas M, Papaconstantinou I, Tiniakos D.
PMID: 31040630
Ann Gastroenterol. 2019 May-Jun;32(3):312-315. doi: 10.20524/aog.2019.0347. Epub 2019 Jan 15.

Lesions with bizarre stromal cells (BSC) have been described in many organs and, although benign, they are frequently misdiagnosed as malignancy. We present the first case of BSC in Crohn's disease with a rare submucosal topography and we review...

Cite
Iliakopoulos K, Tzikanoulas M, Papaconstantinou I, et al. Bizarre stromal cells in Crohn's disease. Ann Gastroenterol. 2019;32(3):312-315doi: 10.20524/aog.2019.0347.
Iliakopoulos, K., Tzikanoulas, M., Papaconstantinou, I., & Tiniakos, D. (2019). Bizarre stromal cells in Crohn's disease. Annals of gastroenterology, 32(3), 312-315. https://doi.org/10.20524/aog.2019.0347
Iliakopoulos, Konstantinos, et al. "Bizarre stromal cells in Crohn's disease." Annals of gastroenterology vol. 32,3 (2019): 312-315. doi: https://doi.org/10.20524/aog.2019.0347
Iliakopoulos K, Tzikanoulas M, Papaconstantinou I, Tiniakos D. Bizarre stromal cells in Crohn's disease. Ann Gastroenterol. 2019 May-Jun;32(3):312-315. doi: 10.20524/aog.2019.0347. Epub 2019 Jan 15. PMID: 31040630; PMCID: PMC6479657.
Copy Download .nbib Format: NLM
Burnout among gastroenterologists: How to manage and prevent it.

United European gastroenterology journal

Buscarini E, Gecse KB, Tiniakos D.
PMID: 32731840
United European Gastroenterol J. 2020 Aug;8(7):832-834. doi: 10.1177/2050640620943466.

No abstract available.

Cite
Buscarini E, Gecse KB, Tiniakos D. Burnout among gastroenterologists: How to manage and prevent it. United European Gastroenterol J. 2020;8(7):832-834doi: 10.1177/2050640620943466.
Buscarini, E., Gecse, K. B., & Tiniakos, D. (2020). Burnout among gastroenterologists: How to manage and prevent it. United European gastroenterology journal, 8(7), 832-834. https://doi.org/10.1177/2050640620943466
Buscarini, Elisabetta, et al. "Burnout among gastroenterologists: How to manage and prevent it." United European gastroenterology journal vol. 8,7 (2020): 832-834. doi: https://doi.org/10.1177/2050640620943466
Buscarini E, Gecse KB, Tiniakos D. Burnout among gastroenterologists: How to manage and prevent it. United European Gastroenterol J. 2020 Aug;8(7):832-834. doi: 10.1177/2050640620943466. PMID: 32731840; PMCID: PMC7435002.
Copy Download .nbib Format: NLM
RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES.

medRxiv : the preprint server for health sciences

Fitzgerald KC, Mecoli CA, Douglas M, Harris S, Aravidis B, Albayda J, Sotirchos ES, Hoke A, Orbai AM, Petri M, Christopher-Stine L, Baer AN, Paik JJ, Adler BL, Tiniakou E, Timlin H, Bhargava P, Newsome SD, Venkatesan A, Chaudhry V, Lloyd TE, Pardo CA, Stern BJ, Lazarev M, Truta B, Saidha S, Chen ES, Sharp M, Gilotra N, Kasper EK, Gelber AC, Bingham CO, Shah AA, Mowry EM.
PMID: 33564774
medRxiv. 2021 Feb 05; doi: 10.1101/2021.02.03.21251069.

BACKGROUND: People with autoimmune or inflammatory conditions who take immunomodulatory/suppressive medications may have a higher risk of novel coronavirus disease 2019 (COVID-19). Chronic disease care has also changed for many patients, with uncertain downstream consequences.OBJECTIVE: Assess whether COVID-19 risk...

Cite
Fitzgerald KC, Mecoli CA, Douglas M, et al. RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES. medRxiv. 2021;doi: 10.1101/2021.02.03.21251069.
Fitzgerald, K. C., Mecoli, C. A., Douglas, M., Harris, S., Aravidis, B., Albayda, J., Sotirchos, E. S., Hoke, A., Orbai, A. M., Petri, M., Christopher-Stine, L., Baer, A. N., Paik, J. J., Adler, B. L., Tiniakou, E., Timlin, H., Bhargava, P., Newsome, S. D., Venkatesan, A., Chaudhry, V., Lloyd, T. E., Pardo, C. A., Stern, B. J., Lazarev, M., Truta, B., Saidha, S., Chen, E. S., Sharp, M., Gilotra, N., Kasper, E. K., Gelber, A. C., Bingham, C. O., Shah, A. A., & Mowry, E. M. (2021). RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.02.03.21251069
Fitzgerald, Kathryn C, et al. "RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.02.03.21251069
Fitzgerald KC, Mecoli CA, Douglas M, Harris S, Aravidis B, Albayda J, Sotirchos ES, Hoke A, Orbai AM, Petri M, Christopher-Stine L, Baer AN, Paik JJ, Adler BL, Tiniakou E, Timlin H, Bhargava P, Newsome SD, Venkatesan A, Chaudhry V, Lloyd TE, Pardo CA, Stern BJ, Lazarev M, Truta B, Saidha S, Chen ES, Sharp M, Gilotra N, Kasper EK, Gelber AC, Bingham CO, Shah AA, Mowry EM. RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES. medRxiv. 2021 Feb 05; doi: 10.1101/2021.02.03.21251069. PMID: 33564774; PMCID: PMC7872366.
Copy Download .nbib Format: NLM
From the origin of NASH to the future of metabolic fatty liver disease.

Gut

Geier A, Tiniakos D, Denk H, Trauner M.
PMID: 33632710
Gut. 2021 Feb 25; doi: 10.1136/gutjnl-2020-323202. Epub 2021 Feb 25.

Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide. Understanding the pathological and molecular hallmarks from its first description to definitions of disease entities, classifications and molecular phenotypes is crucial for both...

Cite
Geier A, Tiniakos D, Denk H, et al. From the origin of NASH to the future of metabolic fatty liver disease. Gut. 2021;doi: 10.1136/gutjnl-2020-323202.
Geier, A., Tiniakos, D., Denk, H., & Trauner, M. (2021). From the origin of NASH to the future of metabolic fatty liver disease. Gut, . https://doi.org/10.1136/gutjnl-2020-323202
Geier, Andreas, et al. "From the origin of NASH to the future of metabolic fatty liver disease." Gut vol. (2021). doi: https://doi.org/10.1136/gutjnl-2020-323202
Geier A, Tiniakos D, Denk H, Trauner M. From the origin of NASH to the future of metabolic fatty liver disease. Gut. 2021 Feb 25; doi: 10.1136/gutjnl-2020-323202. Epub 2021 Feb 25. PMID: 33632710; PMCID: PMC8292567.
Copy Download .nbib Format: NLM
Prevalence of avascular necrosis in idiopathic inflammatory myositis: a single center experience.

Rheumatology (Oxford, England)

Bourji KI, Mecoli CA, Paik JJ, Albayda J, Tiniakou E, Kelly W, Lloyd TE, Mammen A, Ahlawat S, Christopher-Stine L.
PMID: 34175928
Rheumatology (Oxford). 2021 Jun 27; doi: 10.1093/rheumatology/keab493. Epub 2021 Jun 27.

OBJECTIVES: To assess the prevalence of avascular necrosis (AVN) in a large cohort of patients with idiopathic inflammatory myopathies (IIM) and define the major associated risk factors.METHODS: We retrospectively reviewed the electronic medical records of all patients with a...

Cite
Bourji KI, Mecoli CA, Paik JJ, et al. Prevalence of avascular necrosis in idiopathic inflammatory myositis: a single center experience. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab493.
Bourji, K. I., Mecoli, C. A., Paik, J. J., Albayda, J., Tiniakou, E., Kelly, W., Lloyd, T. E., Mammen, A., Ahlawat, S., & Christopher-Stine, L. (2021). Prevalence of avascular necrosis in idiopathic inflammatory myositis: a single center experience. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab493
Bourji, Khalil I, et al. "Prevalence of avascular necrosis in idiopathic inflammatory myositis: a single center experience." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab493
Bourji KI, Mecoli CA, Paik JJ, Albayda J, Tiniakou E, Kelly W, Lloyd TE, Mammen A, Ahlawat S, Christopher-Stine L. Prevalence of avascular necrosis in idiopathic inflammatory myositis: a single center experience. Rheumatology (Oxford). 2021 Jun 27; doi: 10.1093/rheumatology/keab493. Epub 2021 Jun 27. PMID: 34175928.
Copy Download .nbib Format: NLM
The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity.

Hippokratia

Batistatou A, Doulis EA, Tiniakos D, Anogiannaki A, Charalabopoulos K.
PMID: 21311630
Hippokratia. 2010 Oct;14(4):241-3.

BACKGROUND AND AIM: Medical humanities is a multidisciplinary field, consisting of humanities (theory of literature and arts, philosophy, ethics, history and theology), social sciences (anthropology, psychology and sociology) and arts (literature, theater, cinema, music and visual arts), integrated in...

Cite
Batistatou A, Doulis EA, Tiniakos D, et al. The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity. Hippokratia. 2010;14(4):241-3
Batistatou, A., Doulis, E. A., Tiniakos, D., Anogiannaki, A., & Charalabopoulos, K. (2010). The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity. Hippokratia, 14(4), 241-3.
Batistatou, A, et al. "The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity." Hippokratia vol. 14,4 (2010): 241-3.
Batistatou A, Doulis EA, Tiniakos D, Anogiannaki A, Charalabopoulos K. The introduction of medical humanities in the undergraduate curriculum of Greek medical schools: challenge and necessity. Hippokratia. 2010 Oct;14(4):241-3. PMID: 21311630; PMCID: PMC3031316.
Copy Download .nbib Format: NLM
Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, Manesis E, Archimandritis A.
PMID: 19624771
Hepatol Res. 2009 Oct;39(10):972-8. doi: 10.1111/j.1872-034X.2009.00534.x. Epub 2009 Jul 13.

AIM: Retinol-binding protein-4 (RBP4) has been proposed as a new adipokine that regulates insulin action in muscles and the liver, and contributes to the pathogenesis of insulin resistance. As non-alcoholic fatty liver disease (NAFLD) is related to insulin resistance,...

Cite
Schina M, Koskinas J, Tiniakos D, et al. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol Res. 2009;39(10):972-8doi: 10.1111/j.1872-034X.2009.00534.x.
Schina, M., Koskinas, J., Tiniakos, D., Hadziyannis, E., Savvas, S., Karamanos, B., Manesis, E., & Archimandritis, A. (2009). Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology, 39(10), 972-8. https://doi.org/10.1111/j.1872-034X.2009.00534.x
Schina, Maria, et al. "Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 39,10 (2009): 972-8. doi: https://doi.org/10.1111/j.1872-034X.2009.00534.x
Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, Manesis E, Archimandritis A. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol Res. 2009 Oct;39(10):972-8. doi: 10.1111/j.1872-034X.2009.00534.x. Epub 2009 Jul 13. PMID: 19624771.
Copy Download .nbib Format: NLM
Long-term extension study of tofacitinib in refractory dermatomyositis.

Arthritis & rheumatology (Hoboken, N.J.)

Paik JJ, Shneyderman M, Gutierrez-Alamillo L, Albayda J, Tiniakou E, Perin J, Purwin G, Leung S, Leung D, Casciola-Rosen L, Koenig AS, Christopher-Stine L.
PMID: 34369109
Arthritis Rheumatol. 2021 Aug 09; doi: 10.1002/art.41944. Epub 2021 Aug 09.

No abstract available.

Cite
Paik JJ, Shneyderman M, Gutierrez-Alamillo L, et al. Long-term extension study of tofacitinib in refractory dermatomyositis. Arthritis Rheumatol. 2021;doi: 10.1002/art.41944.
Paik, J. J., Shneyderman, M., Gutierrez-Alamillo, L., Albayda, J., Tiniakou, E., Perin, J., Purwin, G., Leung, S., Leung, D., Casciola-Rosen, L., Koenig, A. S., & Christopher-Stine, L. (2021). Long-term extension study of tofacitinib in refractory dermatomyositis. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.41944
Paik, Julie J, et al. "Long-term extension study of tofacitinib in refractory dermatomyositis." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.41944
Paik JJ, Shneyderman M, Gutierrez-Alamillo L, Albayda J, Tiniakou E, Perin J, Purwin G, Leung S, Leung D, Casciola-Rosen L, Koenig AS, Christopher-Stine L. Long-term extension study of tofacitinib in refractory dermatomyositis. Arthritis Rheumatol. 2021 Aug 09; doi: 10.1002/art.41944. Epub 2021 Aug 09. PMID: 34369109.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries